Newsletter sign-up

European Wound Management Association
Wednesday, 3 May 2017

We are looking forward to EWMA in Amsterdam and will be attending for the whole conference from 3rd to 5th May 2017.

< Back to overview

Patent news – Patents granted in China and Canada

by Rasmus Lundquist

Reapplix ApS, developers of the unique LeucoPatch active wound therapy, have today announced that they have received notification of key patent grants in China and Canada. The Chinese patent office have granted Reapplix’s patent on the device used when producing a LeucoPatch, using the unique 3CP™ technology developed by the company (patent no. ZL201180045202.2). Furthermore, the Canadian patent office have also granted this patent (patent no. 2,811,777). Reapplix has strong patent protection across multiple key territories.